Interleukin family member ST2 and mortality in acute dyspnoea

Journal of Internal Medicine, 11/12/2010

In patients presenting to the ED with acute dyspnoea, ST2 is a strong and independent predictor of 30–day and 1–year mortality and might improve risk stratification already provided by B–type natriuretic peptide (BNP) or NT–proBNP.

Print Article Summary Cat 2 CME Report